Pharmacological agents that block Hh signaling are soon to enter clinical trials for certain cancers. Given the central role for chondrocytes in the development of osteoarthritis (OA), could the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback